close

Enter

Log in using OpenID

Hepatitis C Treatment Market Research Report 2017-2024

embed
Also government initiatives to control infection and various private NGOs creating awareness about treatment is also fueling the market growth.
Global Market Study
on Hepatitis C
Treatment: Online
Pharmacies Distribution Channel Segment Expected to Register the
Fastest CAGR of 13.5% During 2016 - 2024
Persistence Market Research (PMR) delivers key insights on the global
hepatitis C treatment market in its latest report titled “Hepatitis C Treatment
Market: Global Industry Analysis and Forecast, 2016–2024”. The global
hepatitis C treatment market was valued at US$ 23.9 Bn in 2015 and is
estimated to be valued at US$ 26.6 Bn by 2016. The market is expected to
reach a valuation of US$ 71.13 Bn by the end of 2024, reflecting a CAGR of
13.1% over the forecast period.
Market dynamics
Growth of the global hepatitis C treatment market is primarily driven by factors
such as increase in the prevalence of hepatitis C infections in the U.S. and
Canada and rising per capita healthcare expenditure across the globe. Also
government initiatives to control infection and various private NGOs creating
awareness about treatment is also fueling the market growth. However, high
cost associated with hepatitis C treatment drugs and lack of awareness about
hepatitis C infection in the regions of Asia Pacific, Middle East and Africa, and
Latin America is expected to impede growth of the global hepatitis C treatment
market.
Browse Full Research Report:
https://www.persistencemarketresearch.com/market-research/hepatitis-ctreatment-market.asp
Market forecast
By drug class, the market is segmented into HCV Protease Inhibitors, HCV
Polymerase Inhibitors, HCV NS5A Inhibitors, Combination Therapy and
Interferon & Antiviral which is again sub-divided into various drugs sub
segments. The combination segment is expected to contribute a maximum share
to the global hepatitis C treatment market and register the fastest CAGR of
13.9% during the forecast period. By distribution channel, the market is
segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.
Among these, the hospital pharmacies segment is anticipated to be dominant
throughout the forecast period and is projected to account for about 43.7%
share of the total global hepatitis C treatment market revenue by 2024. The
hospital pharmacies segment is anticipated to emerge as the most attractive
segment in the global hepatitis C treatment market owing to growing instances
of hospitalization and improved accessibility and services. The online
pharmacies segment is expected to register the fastest CAGR during the
forecast period and is estimated to create absolute $ opportunity of US$ 713.8
Mn in 2017 over 2016. The online pharmacies segment is expected to witness
significant growth during the forecast period and this can be attributed to high
availability of hepatitis C treatment drugs and discounts provided by online
pharmacies.
Request and Download Sample [email protected]
https://www.persistencemarketresearch.com/samples/3602
This report covers global and regional trends along with an analysis of the
market potential. North America is estimated to account for 45% share in the
global hepatitis C treatment market by 2016, whereas Asia Pacific is projected
to grow at a healthy CAGR of 14.8% due to increasing awareness about
hepatitis C infections. Europe region is expected to account for 19.6% share in
the global hepatitis C treatment market by 2016 end. Latin America was valued
at US$ 2,915.8 Mn in 2015 and is estimated to reach US$ 3,311.1 Mn by 2016,
with a Y-o-Y growth of 13.6% over 2015–2016. The Middle East and Africa
region was valued at US$ 1,792.5 Mn in 2015 and is estimated to reach US$
1,988.1 Mn by 2016.
Competitive landscape
The global hepatitis C treatment market report features some of the top
companies dominating in the global market. Key market players analyzed in the
report include Merck & Co., Inc., Bristol-Myers Squibb Company, AbbVie
Inc., Gilead Sciences, Inc., Kadmon Holdings, Inc., Johnson & Johnson, F
Hoffmann-La Roche Ltd, and Merck & Co., Inc. Leading companies
functioning in the global hepatitis C treatment market are focusing on
collaborating with healthcare solutions and services providers in order to
advance operational efficiencies and provide improved patient care.
Buy Full Hepatitis C Treatment Market Report
@ https://www.persistencemarketresearch.com/checkout/3602
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our
research model is a unique collaboration of data analytics and market research
methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a
multi-disciplinary approach. At PMR, we unite various data streams from
multi-dimensional sources. By deploying real-time data collection, big data, and
customer experience analytics, we deliver business intelligence for
organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com
Author
shreyas.d
shreyas.d70   documents Email
Document
Category
Health and Medicine
Views
5
File Size
311 KB
Tags
treatment
1/--pages
Report inappropriate content